Elon Musk's Neuralink Receives FDA Approval for Brain Chip: What's Next?

Elon Musk’s Neuralink Corp has reportedly received approval from the U.S. Food and Drug Administration (FDA) to proceed with implanting its brain chip in a second human. This marks a pivotal moment for the neurotechnology company and the future of brain-computer interfaces (BCIs).

Neuralink Achieves Significant Milestone

Neuralink, the brain-chip startup co-founded by Elon Musk, has achieved a significant milestone in its quest to develop brain-computer interface technology. The FDA's green light paves the way for further advancements and potential breakthroughs in treating neurological conditions and enhancing human capabilities.

When Did Neuralink Get FDA Approval?

Neuralink announced in May 2025 it received FDA approval to begin testing its brain-implant technology in humans. On Tuesday, further details about the project and plans were released, solidifying the company's position in the neurotech industry.

How Did Neuralink Get FDA Approval?

The journey to FDA approval involved rigorous testing, data submission, and adherence to strict safety protocols. Neuralink demonstrated the potential benefits of its technology while addressing potential risks and ensuring patient safety. The FDA's comprehensive review process evaluated the device's design, manufacturing, and clinical trial protocols.

This FDA approval signifies a major step forward for Neuralink and the broader field of brain-computer interfaces. Stay tuned for further updates on the progress of this groundbreaking technology.